Rapamycin and IL-2 show a limited effect on the stability of CD8+Foxp3+ Tregs compared to CD4+ Tregs; thus, the former may not completely eradicate GVHD due to conversion into effector T cells (32). Here, CD8A is linked to graft versus host disease.